Oracle
ORCL
Vale SA
VALE
Toll Brothers
TOL
4
D.R. Horton
DHI
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
JAGX Jaguar Health
- 10.670
- -0.240-2.20%
Close Apr 28 16:00 ET
- 10.700
- +0.030+0.28%
Post 19:37 ET
7.19MMarket Cap-0.08P/E (TTM)
11.200High9.700Low201.38KVolume10.980Open10.910Pre Close2.11MTurnover36.48%Turnover RatioLossP/E (Static)674.01KShares532.50052wk High0.99P/B5.89MFloat Cap4.02052wk Low--Dividend TTM552.09KShs Float2501887500.000Historical High--Div YieldTTM13.75%Amplitude4.020Historical Low10.467Avg Price1Lot Size
Jaguar Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.75%11.69M | 52.57%3.51M | 10.49%3.11M | 1.68%2.72M | 19.22%2.35M | -18.36%9.76M | -29.45%2.3M | -10.70%2.81M | -8.39%2.68M | -24.88%1.97M |
| Operating revenue | 14.53%15.58M | 25.10%4.52M | 8.94%4.02M | 4.77%3.63M | 20.26%3.42M | -9.40%13.61M | -7.60%3.61M | -4.82%3.69M | -8.27%3.46M | -17.81%2.84M |
| Cost of revenue | -4.03%1.96M | -18.92%557K | 5.25%541K | -13.03%427K | 24.64%430K | 0.89%2.04M | 38.79%687K | -16.15%514K | 7.68%491K | -24.18%345K |
| Gross profit | 26.02%9.73M | 83.01%2.95M | 11.66%2.57M | 4.99%2.29M | 18.07%1.92M | -22.27%7.72M | -41.66%1.61M | -9.38%2.3M | -11.36%2.19M | -25.02%1.63M |
| Operating expense | -2.59%40.57M | 26.25%11.11M | -11.34%9.83M | -7.74%9.49M | -11.65%10.14M | -6.11%41.64M | -2.78%8.8M | -10.83%11.09M | 15.02%10.29M | -17.61%11.47M |
| Selling and administrative expenses | 4.23%24.02M | 23.22%6.58M | 15.60%5.79M | -2.86%5.84M | -13.04%5.82M | -13.69%23.05M | 12.57%5.34M | -22.92%5.01M | -7.44%6.01M | -25.41%6.7M |
| -Selling and marketing expense | 24.70%4.09M | 86.68%1.54M | 80.22%1.15M | -15.38%743K | -29.83%661K | -36.31%3.28M | -29.64%826K | -52.03%637K | -34.28%878K | -66.77%942K |
| -General and administrative expense | 0.83%19.93M | 11.60%5.03M | 6.18%4.64M | -0.72%5.1M | -10.29%5.16M | -8.28%19.77M | 26.47%4.51M | -15.43%4.37M | -0.48%5.13M | -6.33%5.76M |
| Research and development costs | -11.05%16.54M | 30.93%4.53M | -33.51%4.04M | -14.59%3.65M | -9.70%4.31M | 5.38%18.6M | -19.67%3.46M | 2.37%6.08M | 74.50%4.28M | -3.44%4.78M |
| Operating profit | 9.11%-30.83M | -13.51%-8.16M | 17.36%-7.26M | 11.17%-7.2M | 16.56%-8.22M | 1.44%-33.92M | -14.32%-7.19M | 11.21%-8.79M | -25.05%-8.1M | 16.24%-9.85M |
| Net non-operating interest income expense | 96.38%-231K | 144.35%110K | 132.40%162K | 103.13%108K | 71.99%-611K | 49.84%-6.38M | 90.58%-248K | 81.69%-500K | -36.16%-3.45M | 48.00%-2.18M |
| Non-operating interest expense | -96.38%231K | ---- | ---- | ---- | -71.99%611K | -49.84%6.38M | ---- | ---- | ---- | -48.00%2.18M |
| Total other finance cost | ---- | ---- | -132.40%-162K | -103.13%-108K | ---- | ---- | ---- | --500K | --3.45M | ---- |
| Other net income (expense) | -412.13%-8.19M | -16.64%-2.19M | -311.21%-2.92M | -244.97%-2.54M | -46.09%-542K | -27.21%-1.6M | -372.53%-1.88M | 7,583.33%1.38M | -96.27%-736K | 83.26%-371K |
| Gain on sale of security | -85.07%-9.49M | -45.74%-2.57M | -37.66%-3.09M | -137.53%-1.81M | -462.95%-2.02M | -25,525.00%-5.13M | -161.90%-1.76M | -1,375.00%-2.24M | -207.48%-762K | -54.08%-359K |
| Special income (charges) | -62.57%1.25M | --0 | --0 | --0 | --1.25M | 252.08%3.33M | ---371K | --3.7M | --0 | --0 |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --371K | ---- | ---- | ---- | ---- |
| -Less:Other special charges | 66.32%-1.25M | --0 | ---- | ---- | ---1.25M | -269.04%-3.7M | --0 | ---3.7M | ---- | ---- |
| Other non- operating income (expenses) | -74.50%51K | 47.66%378K | 340.00%168K | -2,903.85%-729K | 2,050.00%234K | -78.95%200K | -81.18%256K | 55.70%-70K | 102.40%26K | -101.44%-12K |
| Income before tax | 6.32%-39.25M | -9.94%-10.23M | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 6.32%-39.25M | -9.94%-10.23M | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M |
| Net income continuous Operations | 6.32%-39.25M | -9.94%-10.23M | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M |
| Minority interest income | -26.29%-759K | -125.90%-314K | -32.54%-167K | 3.55%-136K | 27.18%-142K | 36.13%-601K | 78.65%-139K | -41.57%-126K | -513.04%-141K | -9.55%-195K |
| Net income attributable to the parent company | 6.80%-38.49M | -8.18%-9.92M | -26.69%-9.85M | 21.88%-9.49M | 24.39%-9.23M | 12.97%-41.3M | -20.96%-9.17M | 37.88%-7.78M | -29.71%-12.15M | 32.16%-12.2M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 6.80%-38.49M | -8.18%-9.92M | -26.69%-9.85M | 21.88%-9.49M | 24.39%-9.23M | 12.97%-41.3M | -20.96%-9.17M | 37.88%-7.78M | -29.71%-12.15M | 32.16%-12.2M |
| Basic earnings per share | 95.12%-130.69 | 89.98%-18.7722 | 95.33%-26.25 | 90.23%-101 | 97.49%-90 | 91.79%-2.68K | 96.40%-187.3646 | 94.58%-562.5 | 91.65%-1.03K | 86.35%-3.58K |
| Diluted earnings per share | 95.12%-130.69 | 89.98%-18.7722 | 95.33%-26.25 | 90.23%-101 | 97.49%-90 | 91.79%-2.68K | 96.40%-187.3646 | 94.58%-562.5 | 91.65%-1.03K | 86.35%-3.58K |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀